Intervention

ICS

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions9

Lead sponsors shown4

Clinical trials

4 shown

Tiotropium Plus Olodaterol vs Inhaled Corticosteroids (ICS) Regimens in the Portuguese Primary Care Setting (TIOLCOR Study)NCT04402515 · 2021-10-28

Eosinophil-guided Reduction of Inhaled CorticosteroidsNCT04481555 · 2021-06-28

Systematic Approach for the Diagnosis and Treatment of Obstructive Lung DiseasesNCT02488590 · 2015-07-01

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenNCT01985334 · 2014-02-14

Common conditions

COPD2 Asthma1 Azithromycin1 Chronic Obstructive Pulmonary Disease1 COPD Exacerbation1 Inhaled Corticosteroid1 Overlap Syndrome1 Pneumonia1 Pulmonary Disease, Chronic Obstructive1

Leading sponsors

Boehringer Ingelheim1 Chronic Obstructive Pulmonary Disease Trial Network, Denmark1 KU Leuven1 Novartis Pharmaceuticals1

Trial status mix

COMPLETED2

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE42

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.